Top Tweets for #CMSC17
Drs. Edward Fox, Lori Mayer, and @SKriegerMD discuss #MS patient stories and risks/benefits of DMTs #CMSC17 #CME #CE https://t.co/yT7ejY6tqF
Drs. Edward Fox, Lori Mayer, and @SKriegerMD discuss #MS patient stories and risks/benefits of DMTs #CMSC17 #CME #CE https://t.co/yT7ejY6tqF
What’s the evidence for stopping DMTs in #MultipleSclerosis patients? https://t.co/TKUuIatJi7 #CMSC17
#CMSC17 – Ocrevus Lowers MS Relapse Rates Even Further in Extension Study. Read more >> https://t.co/VkjDhij8zQ
#CMSC17 – Rituxan-treated MS Patients Three Times More Likely to Have Improved Brain Scans. Read more >> https://t.co/UirpWKzPA8
#CMSC17 – Tysabri Improves Mental Outlook for Patients with Secondary Progressive Multiple Sclerosis. Read more >> https://t.co/Stkn5rJ5ih
Patient outcome measures should include patient input, not only reflect what providers feel is important https://t.co/QzwlQ5N2pi #CMSC17
#CMSC17 – Lemtrada’s 2 Year Therapy in RRMS Sustains Efficacy for Over 6 Years Without Additional Treatment. >> https://t.co/8mDRDPtXXZ
#CMSC17 – Many Caregivers of MS Patients Say the Disease Exhausts Them Physically and Emotionally. Read more >> https://t.co/DiJgsOMFy3
#CMSC17 – Physical Activity Halts Depression in Young MS Patients, Canadian Study Shows. Read more >> https://t.co/b4kC4d2vIl
#CMSC17 – Celgene’s Investigational Therapy Ozanimod Safe, Effective in Treating RMS, Clinical Trial Finds. Read >> https://t.co/f3kZBddpN2
#CMSC17 – Rituxan-treated MS Patients Three Times More Likely to Have Improved Brain Scans. Read more >> https://t.co/UirpWKzPA8
#CMSC17 – Review Suggests Certain MS Patient Groups May Discontinue Disease-Modifying Treatments. Read more >> https://t.co/L9abDPvmjr
#CMSC17 – Cladribine Reduced Annual MS Relapse Rate by 55% to 57%, Trials Show. Read more >> https://t.co/1NdtGDAcd7
#CMSC17 - Ocrevus, Progressive MS and Other Research Highlights: Interview with CMSC's Robert Lisak https://t.co/N1vgC59HWo
Review suggests halting therapy may be OK in certain subsets of patients later in the disease course. https://t.co/JLz3pbSLod #CMSC17
#CMSC17 – Ocrevus, Progressive MS and Other Research Highlights: An Interview with CMSC’s… https://t.co/aBDptPTgpq
#CMSC17 – MS Patients Should Contribute to Outcome Measure Development, Study Argues. Read more >> https://t.co/ghf0QQqtux
#CMSC17 – Relapse After First Lemtrada Course No Indication of Poor Long-Term Outcome, Study Finds. Read more >> https://t.co/Pt7BKungDR
Last Seen Hashtags on Sotwe
รับงานเครือสหพัฒน์
Seen from Thailand
omeglegames
Seen from United States
minichat
Seen from Saudi Arabia
NudeOnBalcony
Seen from Belgium
nolimit nolimit videos
Seen from Brazil
سكس_سعودي
Seen from Algeria
turk zenci
Seen from Germany
public
Seen from Mexico
incestoconmamá
Seen from Turkey
فيمبوي
Seen from Netherlands
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.3M followers
Bill Gates
@billgates
65.1M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers